Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
This report contains market size and forecasts of Micafungin Sodium for Injection in global, including the following market information:
Global Micafungin Sodium for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Micafungin Sodium for Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Micafungin Sodium for Injection companies in 2021 (%)
The global Micafungin Sodium for Injection market was valued at 350.6 million in 2021 and is projected to reach US$ 297.9 million by 2028, at a CAGR of -2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
50 mg Single-use Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Micafungin Sodium for Injection include Astellas. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Micafungin Sodium for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Micafungin Sodium for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Micafungin Sodium for Injection Market Segment Percentages, by Type, 2021 (%)
50 mg Single-use Vial
100 mg Single-use Vial
Global Micafungin Sodium for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Micafungin Sodium for Injection Market Segment Percentages, by Application, 2021 (%)
Candidemia
Respiratory Mycosis
Gastrointestinal Mycosis
Global Micafungin Sodium for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Micafungin Sodium for Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Micafungin Sodium for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Micafungin Sodium for Injection revenues share in global market, 2021 (%)
Key companies Micafungin Sodium for Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Micafungin Sodium for Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas

LEAVE A REPLY

Please enter your comment!
Please enter your name here